A carregar...
Cyclooxygenase-2 in glioblastoma multiforme
Glioblastoma multiforme (GBM) represents the most prevalent brain primary tumor, yet there is a lack of effective treatment. With current therapies, fewer than 5% of patients with GBM survive more than 5 years after diagnosis. Mounting evidence from epidemiological studies reveals that the regular u...
Na minha lista:
| Publicado no: | Drug Discov Today |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5226867/ https://ncbi.nlm.nih.gov/pubmed/27693715 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drudis.2016.09.017 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|